Effect of anti-tumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections
about
Circulating lipoproteins are a crucial component of host defense against invasive Salmonella typhimurium infection.Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation.Gamma irradiation or CD4+-T-cell depletion causes reactivation of latent Salmonella enterica serovar Typhimurium infection in C3H/HeN miceIgh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens.Redundancy in tumor necrosis factor (TNF) and lymphotoxin (LT) signaling in vivo: mice with inactivation of the entire TNF/LT locus versus single-knockout miceEffect of interleukin 12 neutralization on host resistance and gamma interferon production in mouse typhoid.Role of alphabeta and gammadelta T cells in the host response to Salmonella infection as demonstrated in T-cell-receptor-deficient mice of defined Ity genotypes.Systemic infection of mice by wild-type but not Spv- Salmonella typhimurium is enhanced by neutralization of gamma interferon and tumor necrosis factor alpha.Intracellular adhesion molecule 1 plays a key role in acquired immunity to salmonellosisInflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets.Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo.Salmonella exploits caspase-1 to colonize Peyer's patches in a murine typhoid modelAntimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro.The crucial role of polymorphonuclear leukocytes in resistance to Salmonella dublin infections in genetically susceptible and resistant mice.Bacterial growth rate and host factors as determinants of intracellular bacterial distributions in systemic Salmonella enterica infections.Effect of in vivo neutralization of tumor necrosis alpha on the efficacy of antibiotic treatment in systemic Salmonella enterica infections.Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium.Disruption of the genes for ClpXP protease in Salmonella enterica serovar Typhimurium results in persistent infection in mice, and development of persistence requires endogenous gamma interferon and tumor necrosis factor alpha.Role of nitric oxide in host defense in murine salmonellosis as a function of its antibacterial and antiapoptotic activities.Neutrophils prevent extracellular colonization of the liver microvasculature by Salmonella typhimurium.Contrasting roles of SPARC-related granuloma in bacterial containment and in the induction of anti-Salmonella typhimurium immunity.Human IgG isotypes and activating Fcγ receptors in the interaction of Salmonella enterica serovar Typhimurium with phagocytic cells.Within-host spatiotemporal dynamics of systemic Salmonella infection during and after antimicrobial treatment.Virulent Salmonella enterica infections can be exacerbated by concomitant infection of the host with a live attenuated S. enterica vaccine via Toll-like receptor 4-dependent interleukin-10 production with the involvement of both TRIF and MyD88.
P2860
Q33401232-71AF61DE-266C-465C-9539-6C303A5B715CQ33765245-4FBEC639-4199-42FB-8193-D0E63FF9D338Q33768948-59C7D4F3-F027-42C8-84F7-0BACEC746E94Q34002939-E9CC2332-160B-42D3-8367-421F9F296B48Q34443174-2858C3AE-441C-43A6-AFF5-AE7D977E1023Q35462723-A0872112-537D-4A17-863B-3ADF3FCC6BC8Q35549483-9FF05B9F-C12A-48ED-BA73-BEE55C624387Q35560441-6B8E1DAD-54A8-42B7-B4DF-5565CDE89959Q36044878-AFC41566-669F-4E3F-ACC6-91977E68AB5EQ36335932-760C687F-6123-4040-8738-3647FAF93105Q36368755-B8081C97-A215-4F1B-A3C5-E075867AFFFBQ36368780-AF5C1BEC-4C9F-463C-898F-218E1A4CFD37Q36368785-892BD9B3-E58F-4AF5-877F-E57F10E5EF2CQ36505591-666C0535-F873-4F9E-BD9A-8D6B18F2211DQ37451040-452DB2B6-AAB8-4E64-B605-0E37777A7B61Q37705093-A722D7F6-9946-418F-8437-538D8D62C48EQ39509475-935AB7E2-6666-49B4-A13A-EF008B5C7BC8Q39519935-49DEEC8E-DAAB-4DC3-BE4B-70EC1887345BQ39655032-95D4D9CD-5B3F-429C-9ABA-7EF1CF628CCAQ39824497-A57203FB-D466-4F89-A30A-AE023A31A9C5Q42576505-3371E845-940C-4A8D-84B5-D75CD2F120ADQ45267991-2A551218-2CE3-4965-85AD-8208225609A7Q49939409-5F7BC0E6-F551-4B41-9D36-1E2273969CBEQ50064774-8FAF7B4A-F551-473F-A367-E7F1A2B46ADC
P2860
Effect of anti-tumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections
description
1995 nî lūn-bûn
@nan
1995 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Effect of anti-tumor necrosis ...... primary Salmonella infections
@ast
Effect of anti-tumor necrosis ...... primary Salmonella infections
@en
type
label
Effect of anti-tumor necrosis ...... primary Salmonella infections
@ast
Effect of anti-tumor necrosis ...... primary Salmonella infections
@en
prefLabel
Effect of anti-tumor necrosis ...... primary Salmonella infections
@ast
Effect of anti-tumor necrosis ...... primary Salmonella infections
@en
P2093
P2860
P1476
Effect of anti-tumor necrosis ...... primary Salmonella infections
@en
P2093
Hormaeche CE
Mastroeni P
Skepper JN
P2860
P304
P407
P577
1995-09-01T00:00:00Z